drugset / Trial / NCT03454529

The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer

NCT03454529

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this pilot phase II trial is to identify the molecular and genetic mechanisms by which statins influence breast cancer cell proliferation. Simvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and reduce the aggressiveness of breast cancer cells.

Timeline

Start
2018-03-09
Primary completion
2021-10-06
Completion
2021-10-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule Oral